[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100657988":3},{"organization":4,"outcomesModule":7,"designInfo":23,"detailedDescription":17,"studyPopulation":17,"armGroups":29,"interventions":34,"overallOfficials":39,"centralContacts":43,"locations":53,"responsibleParty":66,"collaborators":17,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":71,"sex":77,"minAge":78,"maxAge":17,"enrollmentInfo":79,"targetDuration":17,"studyType":82,"phases":83,"briefSummary":84,"conditions":85,"keywords":90,"overallStatus":98,"whyStopped":17,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":103,"completionDateStruct":105,"leadSponsor":107,"locationsCount":108},{"fullName":5,"class":6},"The Cleveland Clinic","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":17,"otherOutcomes":18},[9,13],{"measure":10,"description":11,"timeFrame":12},"The Dementia Knowledge Assessment Tool (DKAT2)","Dementia knowledge will be assessed using the 21-item Dementia Knowledge Assessment Tool Version 2 (DKAT2), which was developed to assess foundation-level knowledge of dementia. Each item has three response options: Yes, No, and Don't Know. Each correct response is assigned 1 point, while an incorrect or Don't Know response is assigned 0 points. Total scores range from 0 to 21, with higher scores indicating greater dementia knowledge.\n\nThe baseline and follow up assessment may be completed either independently using a paper questionnaire or as an interviewer-administered questionnaire by study personnel. The change in total DKAT2 score from baseline to post-intervention will be assessed.","Participants will complete the DKAT2 at baseline, and 1-30 days after reviewing the toolkit at follow-up telephone encounter. The follow-up assessment window may extend 30 additional days if participants wish to remain in the study.",{"measure":14,"description":15,"timeFrame":16},"Patient Education Materials Assessment Tool (PEMAT)","Patient Education Materials Assessment Tool (PEMAT), will be used to assess understandability and actionability of print educational material. The PEMAT provides two domain scores: understandability and actionability. Understandability is assessed using 17 items, and actionability is assessed using 7 items. Each applicable item is scored as 1 (agree) or 0 (disagree). Domain scores are calculated as the percentage of applicable items receiving a score of 1. Scores range from 0% to 100% for each domain, with higher scores indicating greater understandability and actionability. Understandability and actionability scores will be reported separately. The PEMAT may be completed as an interviewer-administered questionnaire by study personnel.","PEMAT will be completed 1-30 days after reviewing the toolkit at follow-up telephone encounter along with DKAT2. The follow-up assessment window may extend 30 additional days if participants wish to remain in the study.",null,[19],{"measure":20,"description":21,"timeFrame":22},"Participant-Reported Educational Material Evaluation and Engagement","There are four open ended questions that will be evaluated to determine thoughts on the toolkit's strengths and areas for improvement.\n\n1. What are the strengths of this educational material?\n2. How much of the booklet did you read?\n3. Did you find the booklet helpful? (Agree\u002Fdisagree)\n4. What areas about Alzheimer's dementia did you learn about in the educational booklet to foster conversations?\n\nThese questions will be completed as an interviewer-administered questionnaire by study personnel.","These four questions will be completed 1-30 days after reviewing the toolkit at follow-up telephone encounter along with DKAT2 and PEMAT. The follow-up assessment window may extend 30 additional days if participants wish to remain in the study.",{"allocation":24,"interventionModel":25,"interventionModelDescription":17,"primaryPurpose":26,"observationalModel":17,"timePerspective":17,"maskingInfo":27},"NA","SINGLE_GROUP","SUPPORTIVE_CARE",{"masking":28,"maskingDescription":17,"whoMasked":17},"NONE",[30],{"label":31,"type":6,"description":17,"interventionNames":32},"The Choose Your Own Adventure Patient Journey with Dementia booklet (CYOA booklet)",[33],"Other: CYOA booklet",[35],{"type":6,"name":36,"description":37,"armGroupLabels":38,"otherNames":17},"CYOA booklet","The purpose of the educational booklet in a CYOA format booklet is to provide educational information about the progression of dementia and to help patients to think about potential future medical decisions that may need to be made for them. By being more informed, patients can discuss their wishes with their family members or future caregivers, include preferences in advanced directives, and\u002For have a discussion with their medical provider about their future care preferences.",[31],[40],{"name":41,"affiliation":5,"role":42},"Kimberlee Fong, DO","PRINCIPAL_INVESTIGATOR",[44,49],{"name":45,"role":46,"phone":47,"phoneExt":17,"email":48},"Holly Renner, RN","CONTACT","2162999529","rennerh2@ccf.org",{"name":50,"role":46,"phone":51,"phoneExt":17,"email":52},"Toyomi Goto","216 444-8424","GOTOT@ccf.org",[54],{"facility":5,"status":17,"city":55,"state":56,"zip":57,"country":58,"countryCode":59,"cosmosGeoPoint":60,"geoPoint":65,"contacts":17},"Cleveland","Ohio","44195","United States","US",{"type":61,"coordinates":62},"Point",[63,64],-81.69541,41.4995,{"lat":64,"lon":63},{"type":42,"investigatorFullName":67,"investigatorTitle":68,"investigatorAffiliation":5,"oldNameTitle":17,"oldOrganization":17},"Kimberlee Fong","Principal Investigator","100657988","choose-myself-before-losing-myself-100657988",false,"NCT07846566","Choose Myself (Before) Losing Myself","Choose Myself (Before) Losing Myself: Providing Educational Information to Empower Alzheimer's Dementia Patients and Their Caregivers Utilizing Gamification Techniques Such as Choose Your Own Adventure.","CYOA","Inclusion Criteria:\n\n* Participants are at least 18 years of age\n* Patients including those: newly diagnosed (within 30 days of informed consent discussion) and established patients diagnosed with mild cognitive impairment or clinical suspicion of mild Alzheimer's dementia diagnosis based on Montreal Cognitive Assessment score (MoCA): 14+, Mini Mental State Exam (MMSE) score: 21+ or Functional Assessment Staging Toll (FAST) score: 1-4\n* Able to read and respond to questions in English (workbook is not available in any other language and survey instruments are validated in English language).\n\nExclusion Criteria:\n\n* Individuals who lack decisional capacity\n* Individuals who possess comorbid conditions that, in the opinion of the investigator, would place unnecessary additional burden upon a patient for study participation or patients for whom participation the study would not be in their best interests.","ALL","18 Years",{"count":80,"type":81},25,"ESTIMATED","INTERVENTIONAL",[24],"The purpose of this study is to see if an educational interactive booklet about how dementia progresses throughout a person's life can be a helpful tool for patients to think about future decisions that might need to be made regarding their medical care and helping patients discuss their diagnosis and possible future medical decisions with their family or future caregivers.",[86,87,88,89],"Dementia (Diagnosis)","Mild Cognitive Impairment","Alzheimer's Disease Dementia","Alzheimer's Disease",[91,92,93,94,95,96,97],"dementia support","cognitive impairment","memory loss","dementia","Alzheimer's disease","Alzheimer's","mild Alzheimer's dementia","NOT_YET_RECRUITING","2026-09-22",{"date":101,"type":102},"2026-09-29","ACTUAL",{"date":104,"type":81},"2026-10-30",{"date":106,"type":81},"2027-07-31",{"name":5,"class":6},1]